Literature DB >> 8605114

Massive cytogenetic heterogeneity in a pancreatic carcinoma: fifty-four karyotypically unrelated clones.

L Gorunova1, B Johansson, S Dawiskiba, A Andrén-Sandberg, Y Jin, N Mandahl, S Heim, F Mitelman.   

Abstract

Chromosome analysis after short-term culture revealed remarkable cytogenetic heterogeneity in a pancreatic carcinoma. The patient had no prior history of radio- or chemotherapy. A total of 54 aberrant, near-diploid, karyotypically unrelated clones were identified, three of which displayed clonal evolution. The abnormalities were unbalanced in 30% of the clones. From one to eight karyotypic anomalies per clone were found. Numerical changes were rare, whereas structural aberrations were numerous and diverse and included deletions, duplication, insertions, inversions, translocations, ring formation, and telomeric associations. All chromosomes except No. 15 were involved in structural rearrangements, chromosomes 1, 6, 7, 8, 11, and 12 being the most frequently affected. A similarly massive cytogenetic polyclonality has never been reported previously. Although the spectrum of epithelial neoplasms characterized by karyotypically unrelated clones is increasing, the pathogenetic role of this type of cytogenetic intratumor heterogeneity remains unknown.

Entities:  

Mesh:

Year:  1995        PMID: 8605114     DOI: 10.1002/gcc.2870140404

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity.

Authors:  D Gisselsson; L Pettersson; M Höglund; M Heidenblad; L Gorunova; J Wiegant; F Mertens; P Dal Cin; F Mitelman; N Mandahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

Authors:  E Heinmöller; W Dietmaier; H Zirngibl; P Heinmöller; W Scaringe; K W Jauch; F Hofstädter; J Rüschoff
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

3.  Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  H Fujii; M Inagaki; S Kasai; N Miyokawa; Y Tokusashi; E Gabrielson; R H Hruban
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

5.  Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathology.

Authors:  María Laura Gutiérrez; Luís Muñoz-Bellvis; María del Mar Abad; Oscar Bengoechea; María González-González; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

6.  Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects.

Authors:  N Zojer; M Fiegl; L Müllauer; A Chott; S Roka; J Ackermann; M Raderer; H Kaufmann; A Reiner; H Huber; J Drach
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

7.  Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q11 with consistent loss of 18q12-qter and frequent gain of 18p.

Authors:  M Höglund; L Gorunova; T Jonson; S Dawiskiba; A Andrén-Sandberg; G Stenman; B Johansson
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.